Skip to main content
Top
Published in: AIDS and Behavior 3/2019

01-10-2019 | Human Immunodeficiency Virus | Commentary

Ending the HIV Epidemic in the United States Must Start with the South

Authors: Kirk D. Henny, William L. Jeffries IV

Published in: AIDS and Behavior | Special Issue 3/2019

Login to get access

Excerpt

The United States (U.S.) is at a crossroads for addressing the HIV epidemic in the southern states (“the South”). Since the height of the HIV epidemic in the late 1980s, prevention work has yielded tremendous successes. Scientific analyses, informed programmatic interventions, and community mobilization have substantially reduced new HIV diagnoses annually. However, progress has stagnated in recent years, as annual HIV diagnoses remain stable at approximately 40,000, and HIV-related disparities persist [1]. Disparities are especially evident in the South. Despite comprising just 38% of the U.S. population, the South represented 52% of HIV diagnoses and 45% of persons living with diagnosed HIV infection in 2017 [1]. Moreover, approximately 50% of all undiagnosed HIV infections during 2010–2016 occurred in the South [2]. The factors that contribute to the disproportionate HIV burden in the South are complex and multi-layered. The solutions will require in-kind responses to address these disparities. …
Literature
1.
go back to reference Centers for Disease Control and Prevention. Diagnoses of HIV infection in the United States and dependent areas, 2017. HIV AIDS Surveill Rep. 2017;25:1–82. Centers for Disease Control and Prevention. Diagnoses of HIV infection in the United States and dependent areas, 2017. HIV AIDS Surveill Rep. 2017;25:1–82.
2.
go back to reference Centers for Disease Control and Prevention. Estimated HIV incidence and prevalence in the United States, 2010–2016. HIV AIDS Surveill Rep. 2019;24(1):1–89. Centers for Disease Control and Prevention. Estimated HIV incidence and prevalence in the United States, 2010–2016. HIV AIDS Surveill Rep. 2019;24(1):1–89.
3.
go back to reference Wolitski R, Henny K, Lyles C, et al. Evolution of HIV/AIDS prevention programs–United States, 1981–2006. MMWR Morb Mortal Wkly Rep. 2006;55(21):597–603. Wolitski R, Henny K, Lyles C, et al. Evolution of HIV/AIDS prevention programs–United States, 1981–2006. MMWR Morb Mortal Wkly Rep. 2006;55(21):597–603.
4.
go back to reference Hurt CB, Nelson JA, Hightow-Weidman LB, Miller WC. Selecting an HIV test: a narrative review for clinicians and researchers. Sex Transm Dis. 2017;44(12):739–46.CrossRef Hurt CB, Nelson JA, Hightow-Weidman LB, Miller WC. Selecting an HIV test: a narrative review for clinicians and researchers. Sex Transm Dis. 2017;44(12):739–46.CrossRef
5.
go back to reference Peters PJ, Westheimer E, Cohen S, et al. Screening yield of HIV antigen/antibody combination and pooled HIV RNA testing for acute HIV infection in a high-prevalence population. JAMA. 2016;315(7):682–90.CrossRef Peters PJ, Westheimer E, Cohen S, et al. Screening yield of HIV antigen/antibody combination and pooled HIV RNA testing for acute HIV infection in a high-prevalence population. JAMA. 2016;315(7):682–90.CrossRef
8.
go back to reference Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493–505.CrossRef Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493–505.CrossRef
9.
go back to reference Watson M, Johnson ST, Zhang T, Oster AM. Characteristics of and trends in HIV diagnoses in the Deep South region of the United States, 2012–2017. AIDS Behav. 2019;2019:1–9. Watson M, Johnson ST, Zhang T, Oster AM. Characteristics of and trends in HIV diagnoses in the Deep South region of the United States, 2012–2017. AIDS Behav. 2019;2019:1–9.
11.
go back to reference Adimora AA, Ramirez C, Schoenbach VJ, Cohen MS. Policies and politics that promote HIV infection in the Southern United States. AIDS. 2014;28(10):1393–7.CrossRef Adimora AA, Ramirez C, Schoenbach VJ, Cohen MS. Policies and politics that promote HIV infection in the Southern United States. AIDS. 2014;28(10):1393–7.CrossRef
12.
go back to reference Stringer K, Turan B, McCormick L, et al. HIV-related stigma among healthcare providers in the deep south. AIDS Behav. 2016;20(1):115–25.CrossRef Stringer K, Turan B, McCormick L, et al. HIV-related stigma among healthcare providers in the deep south. AIDS Behav. 2016;20(1):115–25.CrossRef
13.
go back to reference Substance Abuse and Mental Health Services Administration. Key substance use and mental health indicators in the United States: results from the 2016 National Survey on Drug Use and Health HHS Publication No. SMA 17-5044, NSDUH Series H-52 2017; https://www.samhsa.gov/data. Accessed 27 July 2019. Substance Abuse and Mental Health Services Administration. Key substance use and mental health indicators in the United States: results from the 2016 National Survey on Drug Use and Health HHS Publication No. SMA 17-5044, NSDUH Series H-52 2017; https://​www.​samhsa.​gov/​data. Accessed 27 July 2019.
Metadata
Title
Ending the HIV Epidemic in the United States Must Start with the South
Authors
Kirk D. Henny
William L. Jeffries IV
Publication date
01-10-2019
Publisher
Springer US
Published in
AIDS and Behavior / Issue Special Issue 3/2019
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-019-02686-3

Other articles of this Special Issue 3/2019

AIDS and Behavior 3/2019 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.